Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges
Phenotypic heterogeneity has been observed in most malignancies, which represents a considerable challenge for tumor therapy. In recent decades, the biological function and clinical significance of the human leukocyte antigen (HLA)-G have been intensively explored. It is now widely accepted that HLA...
Main Authors: | Aifen Lin, Wei-Hua Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.02164/full |
Similar Items
-
Intratumor Heterogeneity of HLA-G Expression in Cancer Lesions
by: Xia Zhang, et al.
Published: (2020-11-01) -
HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges
by: Aifen Lin, et al.
Published: (2021-06-01) -
Intercellular transfer of HLA‐G: its potential in cancer immunology
by: Aifen Lin, et al.
Published: (2019-01-01) -
HLA-G Genotype/Expression/Disease Association Studies: Success, Hurdles, and Perspectives
by: Giada Amodio, et al.
Published: (2020-07-01) -
Editorial: The Biological and Clinical Aspects of HLA-G
by: Joel LeMaoult, et al.
Published: (2021-02-01)